Cargando…
Lack of clinical evidence of antiviral therapy for human monkeypox: A scoping review
Since May 2022, many human monkeypox cases have been reported from non-endemic countries. This systematic review aimed to evaluate and summarize the existing research on the efficacy and safety of tecovirimat, brincidofovir, and cidofovir for patients with monkeypox. We searched studies that reporte...
Autores principales: | Kuroda, Naoto, Shimizu, Tadashi, Hirano, Daishi, Ishikane, Masahiro, Kataoka, Yuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598785/ https://www.ncbi.nlm.nih.gov/pubmed/36283609 http://dx.doi.org/10.1016/j.jiac.2022.10.009 |
Ejemplares similares
-
Antiviral Treatment against Monkeypox: A Scoping Review
por: Ortiz-Saavedra, Brando, et al.
Publicado: (2022) -
A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox
por: Hung, Yuan-Pin, et al.
Publicado: (2022) -
Antivirals against Monkeypox (Mpox) in Humans: An Updated Narrative Review
por: Bruno, Giuseppe, et al.
Publicado: (2023) -
Effect of the COVID-19 pandemic and state of emergency declarations on the relative incidence of legionellosis and invasive pneumococcal disease in Japan
por: Ghaznavi, Cyrus, et al.
Publicado: (2023) -
Consideration of Monkeypox Surveillance in China, 2022
por: Zhou, Lei, et al.
Publicado: (2022)